We want to be valued not only for our treatments, but also for the way we work
We uphold high ethical standards throughout our value chain by being accountable and transparent, respecting human rights, and maintaining sound governance.
Whether it is finding technological alternatives to animals in science for our research, safeguarding data privacy, or our zero tolerance to bribery and corruption, we apply high standards of ethical practice throughout our business and supply chain.
Integrity also defines how we approach dialogue with our stakeholders, including our suppliers. We want to build trust by listening to their concerns and communicating transparently about LEO Pharma. To build and maintain trust with our stakeholders, we work with a number of programs in our CSR Commitment 2018-2020 that focus on integrity.
Programs that contribute to upholding the high integrity standards of our business:
We are determined to protect our employees by avoiding potential accidents and promoting a safe working environment and culture. Keeping our employees safe is of great importance in everything we do.
Personal data protection
We safeguard the privacy of our employees, patients, doctors and medical staff with whom we engage, and we must protect personal data.
We do not distinguish between regions in our approach to safeguarding individual rights and freedoms, even though some regions have stricter data protection legislation than others. We set the highest bar everywhere.
Integrity is one of LEO Pharma’s core values. We are committed to working against corruption. We uphold high business standards and promote good business conduct globally in our interactions with customers, healthcare professionals, public officials and other business partners.
Animal experimentation is a prerequisite for drug development. We want to adhere to the highest standards in animal research, based on the 3Rs and the EU Directive on the protection of animals used for scientific purposes. The 3Rs ensure replacement, reduction and refinement in the work with research animals. In practice, this means we only use animals if there are no alternatives, and in these cases we use as few animals as possible and minimize the negative impact on each animal.
Third Party Compliance Code
The English version is the effective version. In case of any discrepancy with translated versions the English version is valid.
LEO Pharma Third Party Compliance Code is also available in the following languages:
Read more about our human rights policy below :
Responsible supply chain management
We want to create better supply chains in the pharmaceutical and healthcare industry.
Responsible supply chain management at LEO Pharma covers the processes and systems we have in place to manage our supply chain responsibly and minimise the adverse impact our suppliers have in relation to human rights, anti-corruption and the environment. Responsible supply chain management is important as stakeholder expectations are rising in relation to this area, with increasing requirements from both international guidelines and legislation.
Furthermore, LEO Pharma needs to work actively with responsible supply chain management in order to reap the benefits that can be obtained through risk mitigation and collaborative partnerships. We therefore aim to know the social and environmental impact that we have on and through our supply chain, and actively work with our business partners to continually improve practices.
Learn more about our responsible supply chain management position here.
Danish Initiative for Ethical Trade (DIEH) is a Danish based multi-stakeholder organisation “whose purpose is, through cooperation between different stakeholders, on a non-profit basis, to promote international trade that respects human- and labour rights, environmental considerations and contributes to global sustainable development by strengthening members’ efforts in ethical trade” (https://www.dieh.dk/about-dieh)
For more information about DIEH please visit their website at https://www.dieh.dk
The Pharmaceutical Supply Chain Initiative (PSCI) is a group of pharmaceutical and healthcare companies who share a vision of better, social, environmental and economic outcomes in the communities where they buy. Through PSCI members can share knowledge and expertise across the industry to drive complex, global change more effectively than any one organization alone. PSCI is an industry collaboration established to promote responsible supply chain management and better business conditions across the industry. (https://pscinitiative.org/home)